Stock Events

Fresenius 

€7.25
744
+€0+0% Wednesday 06:14

Statistics

Day High
7.25
Day Low
7.25
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
16.53B
P/E Ratio
37.63
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

8MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1.18
-0.47
0.24
0.95
Expected EPS
0.6772009029345373
Actual EPS
0.5267118133935289

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FREA.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
DaVita
DVA
Mkt Cap12.41B
DaVita Inc. provides kidney dialysis services, directly competing with Fresenius's dialysis services.
Baxter International
BAX
Mkt Cap18B
Baxter International Inc. offers dialysis products and services, competing in the same healthcare segment as Fresenius.
Medtronic
MDT
Mkt Cap99.95B
Medtronic plc manufactures and sells device-based medical therapies, including those that compete with Fresenius's medical devices.
Boston Scientific
BSX
Mkt Cap114.22B
Boston Scientific Corporation develops, manufactures, and markets medical devices that are in direct competition with some of Fresenius's product offerings.
Johnson & Johnson
JNJ
Mkt Cap360.71B
Johnson & Johnson operates in the healthcare sector, offering products and services that compete across several of Fresenius's business lines.
Abbott Laboratories
ABT
Mkt Cap181.3B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products that compete with Fresenius.
Stryker
SYK
Mkt Cap129.28B
Stryker Corporation specializes in medical devices, competing with Fresenius in the medical equipment and services market.
Zimmer Biomet
ZBH
Mkt Cap22.36B
Zimmer Biomet Holdings, Inc. manufactures and markets orthopedic reconstructive products, competing with Fresenius's medical devices segment.
Becton Dickinson
BDX
Mkt Cap66.21B
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products, competing with Fresenius.
Hologic
HOLX
Mkt Cap18.13B
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products that compete with Fresenius's healthcare solutions.

About

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Show more...
CEO
Mr. Michael Sen
Employees
190863
Country
US
ISIN
US35804M1053
WKN
000A1XCZQ

Listings